MGLMX
Price
$18.34
Change
-$0.15 (-0.81%)
Updated
Sep 20 closing price
RRGRX
Price
$7.66
Change
-$0.04 (-0.52%)
Updated
Sep 20 closing price
Ad is loading...

MGLMX vs RRGRX

Header iconMGLMX vs RRGRX Comparison
Open Charts MGLMX vs RRGRXBanner chart's image
MFS Global Real Estate R4
Price$18.34
Change-$0.15 (-0.81%)
VolumeN/A
CapitalizationN/A
DWS RREEF Global Real Estate Secc R6
Price$7.66
Change-$0.04 (-0.52%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MGLMX vs RRGRX Comparison Chart
Loading...
VS
MGLMX vs. RRGRX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLMX is a StrongSell and RRGRX is a Buy.

FUNDAMENTALS
Fundamentals
MGLMX has more cash in the bank: 2.56B vs. RRGRX (182M). MGLMX pays higher dividends than RRGRX: MGLMX (1.87) vs RRGRX (1.47). MGLMX was incepted earlier than RRGRX: MGLMX (10 years) vs RRGRX (8 years). RRGRX is a more actively managed with annual turnover of: 82.00 vs. MGLMX (30.00). MGLMX (0) and RRGRX (0) have matching initial minimum investment requirements. RRGRX annual gain was more profitable for investors over the last year : 26.65 vs. MGLMX (22.89). MGLMX return over 5 years is better than : 13.70 vs. RRGRX (-4.77).
MGLMXRRGRXMGLMX / RRGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years8 years-
Gain YTD8.26412.75665%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.56B182M1,408%
Annual Yield % from dividends1.871.47127%
Returns for 1 year22.8926.6586%
Returns for 3 years-9.95-8.28120%
Returns for 5 years13.70-4.77-288%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZTA49.28-0.21
-0.43%
Azenta
METC10.13-0.09
-0.88%
Ramaco Resources
CE126.90-3.19
-2.45%
Celanese Corp
GOEV1.02-0.03
-2.86%
Canoo
PMCB1.62-0.43
-20.98%
PharmaCyte Biotech